FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MM Gicheru

Research Profile

Living Beings

Cercopithecus aethiops

Disorders

Chemicals & Drugs

Physiology

Lymphocyte Activation

Procedures

Enzyme-Linked Immunosorbent Assay

Co-author Network

Co-Publications
Name
3
CO Anjili
3
JO Olobo
1
Alloys Orago

Publications

TOP 3
Joshua Muli Mutiso; Hitler Rikoi; James Maina Ichagichu; Maria Ndunge Kiio; John Chege Macharia; MM Gicheru
Development of Leishmania vaccines: predicting the future from past and present experience.
J M Mutiso; J C Macharia; MM Gicheru
Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model.
Joshua Muli Mutiso; Evans Taracha; John Chege Macharia; MM Gicheru
Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MM Gicheru (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joshua Muli Mutiso; Hitler Rikoi; James Maina Ichagichu; Maria Ndunge Kiio; John Chege Macharia; MM Gicheru
Development of Leishmania vaccines: predicting the future from past and present experience.
Journal of biomedical research 2013;27(2):85-102.
2012: J M Mutiso; J C Macharia; MM Gicheru
Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model.
Scandinavian journal of immunology 2012;76(5):471-7.
2012: Joshua Muli Mutiso; Evans Taracha; John Chege Macharia; MM Gicheru
Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).
Journal of biomedical research 2012;26(1):8-16.
2012: Joshua M Mutiso; Hitler Rikoi; Evans Taracha; Kellern Wafula; John C Macharia; MM Gicheru
Safety and skin delayed-type hypersensitivity response in vervet monkeys immunized with Leishmania donovani sonicate antigen delivered with adjuvants.
Revista do Instituto de Medicina Tropical de São Paulo 2012;54(1):37-41.
2010: Joshua M Mutiso; John C Macharia; MM Gicheru
A review of adjuvants for Leishmania vaccine candidates.
Journal of biomedical research 2010;24(1):16-25.
2001: JO Olobo; MM Gicheru; CO Anjili
The African Green Monkey model for cutaneous and visceral leishmaniasis.
Trends in parasitology 2001;17(12):588-92.
2001: MM Gicheru; JO Olobo; CO Anjili; Alloys S S Orago; F Modabber; P Scott
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection.
Infection and immunity 2001;69(1):245-51.
1997: MM Gicheru; JO Olobo; CO Anjili
Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease.
Experimental parasitology 1997;85(2):109-16.